1334953-75-1 Usage
General Description
N-((5-(4-chloroquinazolin-6-yl)furan-2-yl)Methyl)-2-(Methylsulfonyl)ethanaMine is a chemical compound that contains a quinazoline ring and a furan ring, as well as a methylsulfonyl group attached to an ethylamine chain. N-((5-(4-chloroquinazolin-6-yl)furan-2-yl)Methyl)-2-(Methylsulfonyl)ethanaMine is a potential candidate for pharmaceutical research and development due to its structural features. It may have applications in the treatment of various medical conditions, although further studies would be necessary to determine its specific properties, uses, and potential side effects. The chemical structure of N-((5-(4-chloroquinazolin-6-yl)furan-2-yl)Methyl)-2-(Methylsulfonyl)ethanaMine makes it a promising target for medicinal chemistry investigations.
Check Digit Verification of cas no
The CAS Registry Mumber 1334953-75-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,4,9,5 and 3 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1334953-75:
(9*1)+(8*3)+(7*3)+(6*4)+(5*9)+(4*5)+(3*3)+(2*7)+(1*5)=171
171 % 10 = 1
So 1334953-75-1 is a valid CAS Registry Number.
1334953-75-1Relevant articles and documents
METHODS FOR THE PREPARATION OF LAPATINIB AND THE SALTS THEREOF
-
, (2012/10/08)
Methods for the synthesis of the pharmaceutically active ingredient Lapatinib and the salts thereof are provided. In particular, such methods utilize intermediates in which the hydroxyl function is protected by a tetrahydropyranyl group providing greater solubility of the intermediates in common organic solvents.
PROCESS AND INTERMEDIATES FOR PREPARING LAPATINIB
-
Page/Page column 19, (2011/10/13)
Provided are a process for preparing lapatinib and its pharmaceutically acceptable salt by use of new intermediates, and a process for obtaining a pharmaceutical form of lapatinib ditosylate monohydrate.
